Feds must embrace telehealth, not overregulate it, post pandemic: expert warns
By
Danielle Brown
Jun 09, 2022
An expansion of telehealth flexibilities has been transformative for the long-term care profession and at least one expert is hoping that the federal government welcomes the changes rather than bog down...
November’s drop in COVID deaths may hint at early nursing home success, experts contend
By
Alicia Lasek
Mar 16, 2021
Between spring pandemic lockdowns and November, mortality rates due to COVID-19 in nursing homes declined significantly — well before a vaccine was approved to treat the disease, according to a new study.
New osteoporosis guidance endorses bisphosphonates as initial treatment
By
Alicia Lasek
Jan 03, 2023
The American College of Physicians’ new guidelines for treating osteoporosis highlight bisphosphonates and suggest an ideal length of therapy.
J&J’s COVID-19 vaccine 74 percent effective, real-world study finds
By
Alicia Lasek
Nov 04, 2021
Data from more than 8,800 vaccinated Mayo Clinic patients has found that a single dose of Johnson & Johnson’s COVID-19 vaccine reduces hospitalization in the face of widely circulating gene variants.
Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
Advocacy groups plead for end to two-year wait for Medicare coverage for disabled
Nov 14, 2008
Healthcare and disability advocacy groups have launched a campaign to end the two-year waiting period the disabled must endure before qualifying for Medicare.
Music intervention rejuvenates certain regions of the older brain: study
By
Alicia Lasek
Apr 24, 2023
Listening to music and playing a musical instrument may help to avert brain aging in the areas related to these actions, researchers in Switzerland and Germany have found.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
CVS Health ‘well positioned’ to serve LTC with future COVID-19 vaccine
By
Danielle Brown
Aug 06, 2020
Long-term care facilities that receive pharmacy services from CVS Health should have sufficient access to a COVID-19 vaccine, once one is ready, executives stated Wednesday morning.
COVID vaccines lost some effectiveness in delta surge, ongoing CDC study finds
By
Alicia Lasek
Aug 25, 2021
The three federally sanctioned COVID vaccines have lost a “moderate” amount of effectiveness against SARS-CoV-19 ever since the delta gene variant became the predominant U.S. strain, the agency reports.